Abstract

The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act

Author(s): Pore R David

Issue: Nov/Dec 2012 - Volume 16, Number 6

Page(s): 446-450

Download in electronic PDF format for $75
  • The Drug Enforcement Agency's Position on
  • The Drug Enforcement Agency's Position on
  • The Drug Enforcement Agency's Position on
  • The Drug Enforcement Agency's Position on
  • The Drug Enforcement Agency's Position on

Abstract

This article provides a summary of the Drug Enforcement Agency’s current interpretation of the Controlled Substances Act as it relates to the “constructive transfer” of certain controlled substances from pharmacist to physician for office administration. The article discusses compliance with the Controlled Substances Act in this context and related legislative and legal activities of individual pharmacists and of the International Academy of Compounding Pharmacists and other groups.

Related Keywords

  • R. David Pore, MA, JD
  • U.S. Drug Enforcement Agency
  • DEA
  • constructive transfer
  • Controlled Substances Act
  • DEA Form 222
  • compounded sterile preparations

Related Categories

  • LEGAL
  • PAIN MANAGEMENT
  • PROFESSIONAL ISSUES

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2012
Pg. 446-450
The Drug Enforcement Agency's Position on "Constructive Transfer" Under the Controlled Substances Act
Author(s): Pore R David
Mar/Apr 2012
Pg. 94-96
View Sample
The International Academy of Compounding Pharmacists Stepping Up Efforts to Remedy Problems Caused by the U.S. Drug Enforcement Administration's "Constructive Transfer" Policy
Author(s): Miller David G
Sep/Oct 2021
Pg. 358-362
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Author(s): Cabaleiro Joe
Jul/Aug 2016
Pg. 351
View Sample
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Author(s): Allen Loyd V Jr
Jul/Aug 2015
Pg. 303-305
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Author(s): Miller David G
Sep/Oct 2020
Pg. 371-379
Safety Standards in Pharmaceutical Compounding, Part 2: A Closer Look at Agency Information, Oversight, and Assistance
Author(s): Greeson Nicole MH, Mixon William, Allan W Chris
Nov/Dec 2011
Pg. 526-527
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse
Author(s): Williams LaVonn A
Mar/Apr 2015
Pg. 104-106
Standing Together Fixing the Drug Quality and Security Act
Author(s): Miller David G
Nov/Dec 2015
Pg. 487-488
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Author(s): Allen Loyd V Jr
Mar/Apr 2018
Pg. 92
PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing
Author(s): Allen Loyd V Jr
Sep/Oct 2009
Pg. 400-403
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications
Author(s): Gilbert John A
Jan/Feb 2020
Pg. 30-36
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Author(s): Dillon L R
Sep/Oct 2017
Pg. 356
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Author(s): Allen Loyd V Jr
Sep/Oct 2012
Pg. 431-433
Use of a Closed-system Drug Transfer Device (PhaSeal) and Impact on Preparation Time
Author(s): Sanchez-Rubio Ferrandez J, Lozano M C, Iglesias I, Sanchez-Rubio Ferrandez L, Rodriguez Vargas B, Moreno Diaz R
Jan/Feb 2002
Pg. 8-10
Compounding with Controlled Substances
Author(s): Whalen Mary Kate
Jan/Feb 2014
Pg. 35-36
U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013
Author(s): Miller David G
Sep/Oct 2012
Pg. 382-384
Legislative/Regulatory Update from the International Academy of Compounding Pharmacists
Author(s): Miller David G
Mar/Apr 2014
Pg. 94-99
A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards
Author(s): Marks Zach
Mar/Apr 2016
Pg. 148-154
Safe Cytotoxic Drug Preparation Using a Closed-system Transfer Device: Technical and Practical Evaluation of a New Device (Vialshield/Texium) Comparatively to a Reference One (Phaseal)
Author(s): Garrigue Philippe, Montana Marc, Ventre Christophe, Savry Amadine, Gauthier-Villano Laurence, Pisano Pascale, Pourroy Bertrand
Sep/Oct 2018
Pg. 401-404
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1
Author(s): Martin Matt